YSXT:NASDAQYSX Tech. Co., Ltd Analysis
Data as of 2026-05-12 - not real-time
$1.01
Latest Price
8/10Risk
Risk Level: High
Executive Summary
YSX Tech. Co., Ltd trades at a markedly low price multiple relative to its industry, with a PE ratio well below the sector average and a sub‑one price‑to‑book ratio, suggesting a valuation discount. However, the company faces significant headwinds: technical indicators are bearish, the 20‑day SMA sits below both the 50‑day and 200‑day averages, RSI is in the mid‑30s, and MACD has turned negative, while volume is on a downward trend. Liquidity is thin – daily volumes are well under average, and the stock’s beta is near zero, reflecting limited price sensitivity but also a lack of market depth. The balance sheet shows modest cash against a sizable debt load, and cash‑flow metrics are negative, leading to an alarming max drawdown.
On the upside, recent partnership announcements signal potential revenue uplift through digital transformation and supply‑chain finance services in China’s auto‑insurance market, which could improve growth prospects if execution materializes.
On the upside, recent partnership announcements signal potential revenue uplift through digital transformation and supply‑chain finance services in China’s auto‑insurance market, which could improve growth prospects if execution materializes.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Bearish technical setup (MACD below signal, RSI < 40)
- Decreasing volume indicating waning buying interest
- Current price near support with limited upside
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strategic partnerships could lift revenue growth
- Valuation discount provides a cushion
- Continued cash‑flow deficits and high drawdown risk
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential upside from digital transformation in China’s insurance sector
- Persistent regulatory and geographic exposure
- Undervalued multiples may attract opportunistic buyers
Key Metrics & Analysis
Financial Health
Revenue Growth20.20%
Profit Margin6.09%
P/E Ratio4.8
ROE18.36%
ROA8.42%
Debt/Equity24.46
P/B Ratio0.8
Op. Cash Flow$-13513699
Free Cash Flow$-14836077
Industry P/E30.2
Technical Analysis
TrendBearish
RSI37.6
Support$0.93
Resistance$1.32
MA 20$1.12
MA 50$1.23
MA 200$1.86
MACDBearish
VolumeDecreasing
Fear & Greed Index88.61
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta0.05
Volatility51.88%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
ZKH
ZKH Group Limited
STOCKZJYL
JIN MEDICAL INTERNATIONAL LTD.
STOCKZJK
ZJK Industrial Co., Ltd.
STOCKZIP
ZipRecruiter, Inc.
STOCKZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKZION
Zions Bancorporation N.A.
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.